Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plant Extracts | 9 | 2021 | 286 | 2.720 |
Why?
|
1-Methyl-4-phenylpyridinium | 10 | 2021 | 30 | 2.340 |
Why?
|
Lactic Acid | 9 | 2021 | 95 | 1.780 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2021 | 807 | 1.730 |
Why?
|
High-Throughput Screening Assays | 6 | 2021 | 65 | 1.650 |
Why?
|
Glycolysis | 9 | 2021 | 68 | 1.510 |
Why?
|
Biological Products | 3 | 2016 | 71 | 1.500 |
Why?
|
Cell Survival | 24 | 2021 | 864 | 1.440 |
Why?
|
Cell Line, Tumor | 24 | 2021 | 2231 | 1.260 |
Why?
|
Glioma | 7 | 2016 | 79 | 1.260 |
Why?
|
Hydroxamic Acids | 2 | 2018 | 32 | 1.210 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2018 | 37 | 1.190 |
Why?
|
Neuroblastoma | 11 | 2012 | 129 | 1.180 |
Why?
|
L-Lactate Dehydrogenase | 3 | 2021 | 62 | 1.070 |
Why?
|
Cytostatic Agents | 2 | 2021 | 7 | 1.010 |
Why?
|
Monoamine Oxidase | 5 | 2012 | 34 | 0.930 |
Why?
|
Mitochondria | 8 | 2012 | 487 | 0.920 |
Why?
|
Antineoplastic Agents, Phytogenic | 5 | 2021 | 110 | 0.900 |
Why?
|
Plants, Medicinal | 4 | 2013 | 68 | 0.900 |
Why?
|
Anti-Inflammatory Agents | 5 | 2017 | 149 | 0.880 |
Why?
|
Glucose | 7 | 2020 | 230 | 0.860 |
Why?
|
Environment | 2 | 2014 | 138 | 0.820 |
Why?
|
Dioscorea | 1 | 2021 | 3 | 0.820 |
Why?
|
Thiophenes | 1 | 2021 | 31 | 0.800 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 626 | 0.790 |
Why?
|
Pyridones | 1 | 2021 | 40 | 0.790 |
Why?
|
Herbicides | 2 | 2012 | 44 | 0.760 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 219 | 0.750 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 2020 | 5 | 0.750 |
Why?
|
Nitric Oxide Synthase | 5 | 2005 | 128 | 0.740 |
Why?
|
Breast Neoplasms | 5 | 2019 | 1502 | 0.720 |
Why?
|
Hydrogen Peroxide | 7 | 2012 | 190 | 0.710 |
Why?
|
Gene Expression | 2 | 2021 | 674 | 0.660 |
Why?
|
Microglia | 3 | 2016 | 166 | 0.640 |
Why?
|
Imidazoles | 2 | 2018 | 126 | 0.640 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 24 | 0.640 |
Why?
|
Boswellia | 1 | 2017 | 2 | 0.620 |
Why?
|
Naphthoquinones | 1 | 2018 | 36 | 0.620 |
Why?
|
Triterpenes | 1 | 2017 | 14 | 0.610 |
Why?
|
Animals | 37 | 2019 | 15081 | 0.610 |
Why?
|
Neurons | 4 | 2018 | 1175 | 0.600 |
Why?
|
Cytokines | 3 | 2020 | 602 | 0.600 |
Why?
|
Melanoma | 1 | 2018 | 96 | 0.590 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 11 | 0.580 |
Why?
|
Nitrogen Dioxide | 1 | 2016 | 10 | 0.580 |
Why?
|
Antioxidants | 6 | 2015 | 416 | 0.570 |
Why?
|
Seeds | 1 | 2017 | 35 | 0.570 |
Why?
|
Vitis | 1 | 2017 | 31 | 0.560 |
Why?
|
Momordica | 2 | 2019 | 14 | 0.550 |
Why?
|
Signal Transduction | 6 | 2018 | 1908 | 0.550 |
Why?
|
Rats | 22 | 2019 | 3483 | 0.550 |
Why?
|
Nerve Growth Factor | 2 | 2018 | 30 | 0.550 |
Why?
|
Neoplasms | 2 | 2020 | 1103 | 0.530 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2017 | 1039 | 0.530 |
Why?
|
Sepsis | 1 | 2016 | 80 | 0.530 |
Why?
|
Humans | 31 | 2023 | 37093 | 0.510 |
Why?
|
Dopamine | 6 | 2004 | 245 | 0.510 |
Why?
|
Neurogenesis | 1 | 2015 | 58 | 0.490 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2019 | 356 | 0.490 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2014 | 39 | 0.480 |
Why?
|
Tumor Cells, Cultured | 10 | 2014 | 502 | 0.470 |
Why?
|
Macrophages | 2 | 2016 | 439 | 0.460 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2012 | 25 | 0.460 |
Why?
|
Lipopolysaccharides | 8 | 2016 | 220 | 0.460 |
Why?
|
Escherichia coli | 1 | 2016 | 453 | 0.460 |
Why?
|
Models, Biological | 3 | 2014 | 677 | 0.460 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 352 | 0.450 |
Why?
|
Pyruvic Acid | 2 | 2003 | 18 | 0.450 |
Why?
|
Cadmium Compounds | 1 | 2013 | 7 | 0.440 |
Why?
|
Ecosystem | 1 | 2014 | 123 | 0.440 |
Why?
|
Selenium Compounds | 1 | 2013 | 11 | 0.440 |
Why?
|
Neuroglia | 2 | 2005 | 124 | 0.440 |
Why?
|
Nanocomposites | 1 | 2013 | 19 | 0.430 |
Why?
|
Organic Chemicals | 1 | 2013 | 35 | 0.430 |
Why?
|
Mitosis | 1 | 2013 | 99 | 0.430 |
Why?
|
Reactive Oxygen Species | 6 | 2018 | 461 | 0.430 |
Why?
|
Oxidative Phosphorylation | 2 | 2010 | 53 | 0.420 |
Why?
|
Mice | 13 | 2016 | 5913 | 0.400 |
Why?
|
Genome | 1 | 2012 | 125 | 0.400 |
Why?
|
MicroRNAs | 1 | 2017 | 426 | 0.390 |
Why?
|
Parkinson Disease | 2 | 2011 | 178 | 0.380 |
Why?
|
Astrocytes | 3 | 2015 | 255 | 0.370 |
Why?
|
Chemokine CCL2 | 3 | 2017 | 85 | 0.370 |
Why?
|
Homeostasis | 1 | 2012 | 188 | 0.370 |
Why?
|
Acids | 1 | 2009 | 18 | 0.350 |
Why?
|
Disulfides | 3 | 2015 | 77 | 0.340 |
Why?
|
Cocaine | 6 | 2018 | 232 | 0.340 |
Why?
|
Benzoquinones | 2 | 2021 | 36 | 0.330 |
Why?
|
Apigenin | 2 | 2019 | 13 | 0.320 |
Why?
|
Nanoparticles | 1 | 2013 | 318 | 0.320 |
Why?
|
Adenosine Triphosphate | 4 | 2017 | 196 | 0.310 |
Why?
|
Oxidopamine | 2 | 2005 | 20 | 0.300 |
Why?
|
Nitric Oxide | 5 | 2018 | 316 | 0.300 |
Why?
|
Oxidative Stress | 3 | 2013 | 938 | 0.290 |
Why?
|
Histone Deacetylases | 2 | 2018 | 56 | 0.290 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 213 | 0.290 |
Why?
|
PC12 Cells | 5 | 2019 | 93 | 0.280 |
Why?
|
Nitric Oxide Synthase Type II | 7 | 2015 | 115 | 0.280 |
Why?
|
Cytoprotection | 2 | 2003 | 36 | 0.280 |
Why?
|
Oxygen Consumption | 4 | 2012 | 103 | 0.270 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 245 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 306 | 0.260 |
Why?
|
Isoenzymes | 3 | 2021 | 161 | 0.260 |
Why?
|
MAP Kinase Signaling System | 2 | 2018 | 169 | 0.260 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 803 | 0.260 |
Why?
|
Cell Cycle | 3 | 2021 | 326 | 0.250 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2016 | 112 | 0.250 |
Why?
|
Acetylcysteine | 3 | 2015 | 62 | 0.250 |
Why?
|
Oxidation-Reduction | 6 | 2012 | 431 | 0.250 |
Why?
|
Smoke | 1 | 2005 | 40 | 0.250 |
Why?
|
Neurotoxins | 1 | 2005 | 57 | 0.240 |
Why?
|
Allyl Compounds | 2 | 2015 | 47 | 0.240 |
Why?
|
Ubiquinone | 1 | 2004 | 22 | 0.240 |
Why?
|
Interferon-gamma | 4 | 2016 | 250 | 0.230 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2017 | 113 | 0.230 |
Why?
|
Acetylcarnitine | 1 | 2003 | 8 | 0.230 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2012 | 421 | 0.230 |
Why?
|
Protective Agents | 1 | 2003 | 25 | 0.220 |
Why?
|
Hydroxydopamines | 1 | 2003 | 4 | 0.220 |
Why?
|
Gluconeogenesis | 1 | 2003 | 10 | 0.220 |
Why?
|
NAD | 1 | 2003 | 50 | 0.220 |
Why?
|
Brain Neoplasms | 3 | 2015 | 111 | 0.220 |
Why?
|
Blotting, Western | 5 | 2012 | 859 | 0.210 |
Why?
|
Chlorides | 2 | 2013 | 56 | 0.210 |
Why?
|
Neurotransmitter Agents | 1 | 2002 | 63 | 0.210 |
Why?
|
Gallic Acid | 2 | 2012 | 15 | 0.200 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 103 | 0.200 |
Why?
|
Breast Feeding | 1 | 2023 | 113 | 0.200 |
Why?
|
Excitatory Amino Acids | 1 | 2001 | 7 | 0.200 |
Why?
|
Phytotherapy | 1 | 2021 | 81 | 0.190 |
Why?
|
Isoquinolines | 1 | 2021 | 45 | 0.190 |
Why?
|
Paclitaxel | 1 | 2021 | 50 | 0.190 |
Why?
|
Glutathione | 4 | 2018 | 179 | 0.190 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2001 | 99 | 0.190 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 120 | 0.190 |
Why?
|
Tetrahydroisoquinolines | 2 | 2021 | 21 | 0.190 |
Why?
|
Benzamides | 1 | 2021 | 78 | 0.190 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 51 | 0.180 |
Why?
|
Glutamic Acid | 1 | 2001 | 128 | 0.180 |
Why?
|
Cyclotides | 1 | 2019 | 4 | 0.180 |
Why?
|
Interleukin-1alpha | 2 | 2017 | 18 | 0.180 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2012 | 364 | 0.170 |
Why?
|
Nerve Growth Factors | 1 | 2019 | 33 | 0.170 |
Why?
|
Drug Interactions | 3 | 2012 | 141 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 222 | 0.170 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 186 | 0.170 |
Why?
|
Nitrites | 4 | 2015 | 46 | 0.160 |
Why?
|
Fish Oils | 1 | 1998 | 12 | 0.160 |
Why?
|
RNA, Messenger | 4 | 2015 | 1207 | 0.160 |
Why?
|
Female | 12 | 2023 | 20969 | 0.160 |
Why?
|
Smoking | 1 | 2005 | 940 | 0.150 |
Why?
|
Neurites | 1 | 2018 | 39 | 0.150 |
Why?
|
Apoptosis | 4 | 2014 | 1398 | 0.150 |
Why?
|
Food | 1 | 1998 | 100 | 0.150 |
Why?
|
Aerobiosis | 2 | 2009 | 15 | 0.150 |
Why?
|
Anaerobiosis | 2 | 2009 | 15 | 0.140 |
Why?
|
I-kappa B Kinase | 1 | 2017 | 44 | 0.140 |
Why?
|
DNA Repair | 1 | 2018 | 188 | 0.140 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 25 | 0.140 |
Why?
|
Ibuprofen | 1 | 2016 | 32 | 0.140 |
Why?
|
Molecular Conformation | 1 | 2017 | 152 | 0.140 |
Why?
|
Gene Silencing | 1 | 2017 | 151 | 0.140 |
Why?
|
Neutrophils | 1 | 2016 | 131 | 0.130 |
Why?
|
DNA Damage | 1 | 2018 | 352 | 0.130 |
Why?
|
Enzyme Activation | 1 | 2017 | 444 | 0.130 |
Why?
|
Hela Cells | 1 | 2017 | 366 | 0.130 |
Why?
|
Manganese Compounds | 2 | 2013 | 16 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 121 | 0.130 |
Why?
|
Microtubules | 1 | 2016 | 120 | 0.130 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2015 | 15 | 0.130 |
Why?
|
Silymarin | 1 | 2015 | 2 | 0.130 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 1015 | 0.130 |
Why?
|
Genes, p53 | 1 | 2015 | 25 | 0.130 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 54 | 0.120 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 409 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 93 | 0.120 |
Why?
|
Histones | 2 | 2015 | 190 | 0.120 |
Why?
|
Cells, Cultured | 2 | 2015 | 1518 | 0.110 |
Why?
|
Sulfonamides | 1 | 2014 | 80 | 0.110 |
Why?
|
Models, Molecular | 1 | 2017 | 808 | 0.110 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2013 | 13 | 0.110 |
Why?
|
Pyrimidines | 1 | 2014 | 118 | 0.110 |
Why?
|
Sulfhydryl Compounds | 1 | 2013 | 47 | 0.110 |
Why?
|
Manganese Poisoning | 1 | 2013 | 22 | 0.110 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 935 | 0.110 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 1998 | 162 | 0.110 |
Why?
|
DNA Fingerprinting | 1 | 2012 | 18 | 0.100 |
Why?
|
Particle Size | 1 | 2013 | 215 | 0.100 |
Why?
|
Heterochromatin | 1 | 2012 | 16 | 0.100 |
Why?
|
Nucleosomes | 1 | 2012 | 29 | 0.100 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.100 |
Why?
|
Time Factors | 3 | 2012 | 1742 | 0.100 |
Why?
|
Ligands | 1 | 2013 | 349 | 0.100 |
Why?
|
Liliaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
Boraginaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
Apiaceae | 1 | 2010 | 3 | 0.100 |
Why?
|
Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 182 | 0.090 |
Why?
|
Melanins | 1 | 2011 | 36 | 0.090 |
Why?
|
Nucleus Accumbens | 4 | 2000 | 82 | 0.090 |
Why?
|
Kinetics | 2 | 2003 | 708 | 0.090 |
Why?
|
Prostate | 1 | 2011 | 154 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2010 | 58 | 0.090 |
Why?
|
Vitamins | 1 | 2011 | 94 | 0.090 |
Why?
|
Corpus Striatum | 4 | 2000 | 104 | 0.090 |
Why?
|
Alcohols | 1 | 2009 | 12 | 0.090 |
Why?
|
Fermentation | 1 | 2009 | 26 | 0.090 |
Why?
|
Ketones | 1 | 2009 | 17 | 0.090 |
Why?
|
Aldehydes | 1 | 2009 | 69 | 0.080 |
Why?
|
Piroxicam | 1 | 2008 | 2 | 0.080 |
Why?
|
Amino Acids | 1 | 2009 | 145 | 0.080 |
Why?
|
MPTP Poisoning | 1 | 2008 | 11 | 0.080 |
Why?
|
DNA Methylation | 1 | 2012 | 325 | 0.080 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2008 | 30 | 0.080 |
Why?
|
Cell Line | 3 | 2015 | 1354 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2021 | 1198 | 0.080 |
Why?
|
Oxidants | 2 | 2005 | 45 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 433 | 0.070 |
Why?
|
Animals, Newborn | 2 | 1998 | 343 | 0.070 |
Why?
|
Superoxides | 2 | 2004 | 53 | 0.070 |
Why?
|
Sympatholytics | 1 | 2005 | 14 | 0.060 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2018 | 84 | 0.060 |
Why?
|
Garlic | 2 | 2015 | 30 | 0.060 |
Why?
|
Pyridinium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
Cell Respiration | 1 | 2004 | 35 | 0.060 |
Why?
|
Electron Transport Complex III | 1 | 2004 | 13 | 0.060 |
Why?
|
Drug Combinations | 1 | 2004 | 98 | 0.060 |
Why?
|
Motor Activity | 3 | 2008 | 418 | 0.060 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2003 | 13 | 0.060 |
Why?
|
Phosphoenolpyruvate | 1 | 2003 | 4 | 0.060 |
Why?
|
Molecular Structure | 2 | 2016 | 492 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 448 | 0.060 |
Why?
|
Propidium | 1 | 2003 | 19 | 0.060 |
Why?
|
Intracellular Membranes | 1 | 2003 | 38 | 0.060 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2023 | 36 | 0.060 |
Why?
|
Monosaccharides | 1 | 2003 | 11 | 0.060 |
Why?
|
Antiparkinson Agents | 1 | 2002 | 12 | 0.050 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2002 | 9 | 0.050 |
Why?
|
Imines | 1 | 2002 | 10 | 0.050 |
Why?
|
Levodopa | 1 | 2002 | 20 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2003 | 167 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 52 | 0.050 |
Why?
|
Membrane Potentials | 1 | 2003 | 223 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2003 | 105 | 0.050 |
Why?
|
Cell Death | 1 | 2003 | 267 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 7 | 2000 | 1618 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2003 | 550 | 0.050 |
Why?
|
Florida | 1 | 2023 | 410 | 0.050 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2001 | 48 | 0.050 |
Why?
|
N-Methylaspartate | 1 | 2001 | 57 | 0.050 |
Why?
|
Mothers | 1 | 2023 | 181 | 0.050 |
Why?
|
Drug Discovery | 1 | 2021 | 82 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 137 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 894 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2000 | 140 | 0.050 |
Why?
|
Biomimetics | 1 | 2019 | 10 | 0.040 |
Why?
|
Triazoles | 1 | 2000 | 86 | 0.040 |
Why?
|
Infant | 1 | 2023 | 1046 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2019 | 38 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2002 | 578 | 0.040 |
Why?
|
Quinolinic Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
Clorgyline | 1 | 1998 | 4 | 0.040 |
Why?
|
Selegiline | 1 | 1998 | 6 | 0.040 |
Why?
|
Sharks | 1 | 1998 | 3 | 0.040 |
Why?
|
Enzyme Induction | 1 | 1998 | 53 | 0.040 |
Why?
|
Protein Conformation | 1 | 2019 | 389 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 133 | 0.040 |
Why?
|
Inflammation | 1 | 2003 | 618 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 1998 | 66 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2000 | 314 | 0.040 |
Why?
|
Dopamine Antagonists | 1 | 1998 | 44 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 1998 | 39 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 1998 | 95 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 1998 | 87 | 0.040 |
Why?
|
Petroselinum | 1 | 2017 | 4 | 0.040 |
Why?
|
Computer Simulation | 1 | 2019 | 362 | 0.040 |
Why?
|
Stress, Physiological | 1 | 1998 | 150 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 1998 | 211 | 0.040 |
Why?
|
Protein Binding | 1 | 2019 | 972 | 0.030 |
Why?
|
Tubulin | 1 | 2016 | 88 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 104 | 0.030 |
Why?
|
Breast | 1 | 2017 | 135 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 360 | 0.030 |
Why?
|
Anthracenes | 1 | 2015 | 13 | 0.030 |
Why?
|
Butadienes | 1 | 2015 | 29 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2015 | 19 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 448 | 0.030 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 91 | 0.030 |
Why?
|
Dacarbazine | 1 | 2015 | 6 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 22 | 0.030 |
Why?
|
Nitriles | 1 | 2015 | 69 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 95 | 0.030 |
Why?
|
Child | 1 | 2023 | 3131 | 0.030 |
Why?
|
Down-Regulation | 1 | 2017 | 435 | 0.030 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 65 | 0.030 |
Why?
|
Lysine | 1 | 2015 | 113 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 113 | 0.030 |
Why?
|
Selenium | 1 | 1997 | 148 | 0.030 |
Why?
|
Cognition | 1 | 1998 | 398 | 0.030 |
Why?
|
Pyridines | 1 | 2015 | 116 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2015 | 110 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2014 | 25 | 0.030 |
Why?
|
Drug Synergism | 1 | 2015 | 177 | 0.030 |
Why?
|
Adipokines | 1 | 2014 | 24 | 0.030 |
Why?
|
Male | 7 | 2012 | 20025 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2014 | 153 | 0.030 |
Why?
|
Thymine | 1 | 2013 | 25 | 0.030 |
Why?
|
Comet Assay | 1 | 2013 | 76 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 133 | 0.030 |
Why?
|
Cell Membrane | 1 | 2015 | 381 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 81 | 0.030 |
Why?
|
Cytochromes c | 1 | 2012 | 53 | 0.030 |
Why?
|
Phosphorylation | 1 | 2015 | 928 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2012 | 51 | 0.030 |
Why?
|
Dihydrotestosterone | 1 | 2011 | 29 | 0.030 |
Why?
|
Caspases | 1 | 2012 | 147 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2013 | 399 | 0.020 |
Why?
|
Brain | 1 | 1998 | 1346 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 1095 | 0.020 |
Why?
|
Pregnancy | 3 | 1998 | 1549 | 0.020 |
Why?
|
Corticosterone | 2 | 1999 | 77 | 0.020 |
Why?
|
Oxygen | 1 | 2008 | 207 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 1609 | 0.010 |
Why?
|
Catechols | 1 | 2002 | 5 | 0.010 |
Why?
|
Free Radicals | 1 | 2002 | 74 | 0.010 |
Why?
|
Receptors, Dopamine D1 | 1 | 2002 | 40 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2002 | 155 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2002 | 515 | 0.010 |
Why?
|
Tritium | 1 | 2000 | 51 | 0.010 |
Why?
|
Amphetamine | 1 | 2000 | 16 | 0.010 |
Why?
|
Stereotyped Behavior | 1 | 2000 | 22 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 143 | 0.010 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2000 | 77 | 0.010 |
Why?
|
Naloxone | 1 | 1999 | 52 | 0.010 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1998 | 24 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1998 | 111 | 0.010 |
Why?
|
Morphine | 1 | 1999 | 85 | 0.010 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 1998 | 50 | 0.010 |
Why?
|
Maze Learning | 1 | 1998 | 105 | 0.010 |
Why?
|
Reference Values | 1 | 1998 | 212 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 1998 | 73 | 0.010 |
Why?
|
Homovanillic Acid | 1 | 1997 | 10 | 0.010 |
Why?
|
Microdialysis | 1 | 1997 | 18 | 0.010 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 1997 | 27 | 0.010 |
Why?
|
Quinpirole | 1 | 1997 | 16 | 0.010 |
Why?
|
Memory | 1 | 1998 | 170 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1998 | 230 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1998 | 305 | 0.010 |
Why?
|